Conduit Pharmaceuticals Stock Price on October 28, 2024
| CDT Stock | 0.1 0.01 11.91% |
If you're considering investing in Conduit Stock, it is important to understand the factors that can impact its price. As of today, the current price of Conduit Pharmaceuticals stands at 0.1, as last reported on the 4th of December, with the highest price reaching 0.10 and the lowest price hitting 0.09 during the day. Conduit Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0024, which signifies that the company had a -0.0024% return per unit of risk over the last 3 months. Conduit Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Conduit Pharmaceuticals' Risk Adjusted Performance of 0.0082, mean deviation of 6.02, and Standard Deviation of 8.08 to double-check the risk estimate we provide.
At this time, Conduit Pharmaceuticals' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 10.9 M in 2024, whereas Total Stockholder Equity is likely to drop (479.9 K) in 2024. . Price Earnings To Growth Ratio is likely to gain to 8.83 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (541.11). Conduit Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Conduit |
Sharpe Ratio = -0.0024
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CDT |
Estimated Market Risk
| 8.08 actual daily | 71 71% of assets are less volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Conduit Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Conduit Pharmaceuticals by adding Conduit Pharmaceuticals to a well-diversified portfolio.
Book Value (0.01) | Enterprise Value 14.8 M | Enterprise Value Ebitda (55.41) | Shares Float 53.7 M | Shares Outstanding 116.8 M |
Related Headline
Verve Therapeutics Headline on 28th of October 2024
VERV LAWSUIT ALERT Levi Korsinsky Notifies Verve Therapeutic... by accesswire.com
NEW YORK, NY ACCESSWIRE October 28, 2024 If you suffered a loss on your Verve Therapeutics, Inc. investment and want to learn about a potential recovery under the federal securitie
Conduit Pharmaceuticals Valuation on October 28, 2024
It is possible to determine the worth of Conduit Pharmaceuticals on a given historical date. On October 28, 2024 Conduit was worth 0.11 at the beginning of the trading date compared to the closed value of 0.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Conduit Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Conduit Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Conduit Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Conduit Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.11 | 0.12 | 0.11 | 0.11 | 8,847,929 | |
10/28/2024 | 0.11 | 0.12 | 0.11 | 0.11 | 4,273,063 |
| 0.11 | 0.11 | 0.10 | 0.10 | 7,012,547 |
| Backtest Conduit Pharmaceuticals | | | Conduit Pharmaceuticals History | | | Conduit Pharmaceuticals Valuation | Previous | Next |
Conduit Pharmaceuticals Trading Date Momentum on October 28, 2024
| On October 29 2024 Conduit Pharmaceuticals was traded for 0.10 at the closing time. Highest Conduit Pharmaceuticals's price during the trading hours was 0.11 and the lowest price during the day was 0.10 . The net volume was 7 M. The overall trading history on the 29th of October contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 9.09% . The overall trading delta to current price is 0.00% . |
Conduit Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Conduit Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Conduit financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Conduit Pharmaceuticals Stock history
Conduit Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Conduit is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Conduit Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Conduit Pharmaceuticals stock prices may prove useful in developing a viable investing in Conduit Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 67.9 M | 37.6 M | |
| Net Loss | -4.4 M | -4.6 M |
Conduit Pharmaceuticals Stock Technical Analysis
Conduit Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Conduit Pharmaceuticals Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Conduit Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Conduit Pharmaceuticals December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Conduit Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Conduit Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Conduit Pharmaceuticals stock market strength indicators, traders can identify Conduit Pharmaceuticals entry and exit signals to maximize returns
Conduit Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Conduit Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Conduit Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Conduit to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0082 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (1.11) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.